China Money Network
Login
Join

China Growth Capital Leads $20M Series A+ Round In ABM Therapeutics

  • August 7, 2020 — 14:37 CST

This Data Is Locked!

This area is available only to Subscribers.

China Growth Capital has led a US$20 million series A+ round in ABM Therapeutics, a Chinese clinical-stage biopharmaceutical company developing a new generation of BRAF... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: